Our guiding principles in Research and Development are to improve proton delivery and clinical precision, shorten treatment time and reduce costs. We are engaged in robust research projects with academic institutions and collaborate with manufacturers to drive innovation and exceptional patient care.
ProCure's research and development team, under the leadership of Niek Schreuder, senior vice president, medical physics and technology, is changing the way proton therapy is administered by continually creating technological solutions to improve the application of proton technology.
ProCure believes in evidence-based medicine. Our network of proton centers will enable our company to make a significant contribution to proton therapy research. We are collaborating with leading academic research centers on clinical research and protocol development to ensure that quality data is captured for analysis.
Mr. Schreuder, senior vice president, medical physics and technology, is one of the foremost medical physicist pioneers in the world. He was director of medical physics at the Midwest Proton Radiotherapy Institute (MPRI) where he was responsible for all medical physics related matters. Mr. Schreuder also served as the medical physicist and project manager for the Indiana University (IU) Cyclotron Facility where he led the medical physics design effort associated with MPRI. Prior to MPRI and IU, he was division head of the operations and development division of the Medical Radiation Group at Ithemba Laboratories for Accelerator Sciences (tLabs) in South Africa. At tLabs, Mr. Schreuder developed the computerized patient positioning system for proton therapy using a commercial robotic arm. Mr. Schreuder earned a BS with honors in radiation physics, a Diploma in Datametrics, and an MS in physical sciences in medical sciences from the University of Stellenbosch in South Africa.